CompletedNCT01668797
What is this study about?Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Colombia, Malaysia, + 4 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01516424
What is this study about?Researchers compared Blonanserin and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingSchizophreniaMedication studyAges 18–64
- Countries
- China
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
CompletedNCT01776112
Official study titleEnhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial
This study has finished and is no longer accepting participants.
In GöttingenSchizophreniaPlacebo comparisonAges 18–55
- Countries
- Germany
- Sponsor
- University Medical Center Goettingen
CompletedNCT00291200
About this title
Enhancing the Prospective Prediction of Psychosis
Read the official source — NCT00291200Official study titleEnhancing the Prospective Prediction of Psychosis
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenSchizophreniaObservational studyAges 12–35
- Countries
- United States, Canada
- Sponsor
- Yale University
CompletedNCT02146547
Official study titleEuropean Long-acting Antipsychotics in Schizophrenia Trial
This study has finished and is no longer accepting participants.
Multiple locations, including InnsbruckSchizophreniaMedication studyAges 18+
- Countries
- United Kingdom, Belgium, Austria, + 13 others
- Sponsor
- UMC Utrecht